Лорд Евгений Лебедев выступил перед Британским Парламентом с речью о важности исследований продления / политика (политические новости, шутки и мемы) :: евгений лебедев :: Живи вечно или умри пытаясь

Как это кто? Плебс разумеется! Плебса много, а %ИМЯ БОГАТЕЯ% у мамы один

Про Деда Мороза я еще лет пять назад узнал!

Шимпанзе не является нашим далёким предком. У людей, шимпанзе, да и других приматов есть общий древний предок всех известных приматов.
Самый далёкий предок не был шимпанзе а совсем другой обезьяной, который может быть общим предком и человекообразных и мартышкиных обезьян.

Исследования продления жизни и Крымский мост...не вижу связи

Ниже содержание его речи. нет там ни слова о Крымском мосте. Зачем все же ты этот абзац протащил?

I'd like to welcome my noble friends to the House and congratulate them on their brilliant
speeches. Mine follows on perfectly from the from the one made by noble Minister Valance
and by Baroness Blackwood. My Lords, I'm delighted to speak on in this debate on the
Gracious Speech. As the new Parliament opens, I want to turn the attention of your
Lordships House to an emerging field which can unlock huge benefits for Britain. Longevity
research. Before going further, I should declare my interest as trustee of Evolution
Foundation, which is on the register. A country faces a medical crisis as life expectancy has
increased, the proportion of time spent and good health is going down.
We must urgently develop a new approach to medicine, one that tackles root causes of
diseases, many of which, including heart disease, diabetes and Alzheimer's, are
fundamentally the same. According to latest research. The discovery of the 12 hallmarks of
ageing, including the loss of stem cells and metabolic dysregulation, are central to our
understanding of what drives age-related disease. Also, groundbreaking new theory
suggests ageing is driven by the loss of vital regulatory information within our cells, rather
than primarily accumulating damage over time as previously thought. Through epigenetic
reprogramming, we could potentially reset our bodies tissues to a more functional state.
Scientific studies have already reversed vision loss in mice and human trials are set to begin
next year. There's the discovery of drugs called synolytics, which reverse aspects of ageing
while eliminating senescent zombie cells. These cells contribute to chronic disease and
cancer.
Cutting edge breakthroughs like these, driven by labs right here in the UK, are informing
how we tackle the underlying factors behind ageing, rather than just tackling symptoms. My
Lords, we stand at the precipice of a medical revolution catalysed by medical monitoring
devices, genomics and our understanding of what drives ageing. Britain can become a
global leader in longevity science and capturing this beachhead will benefit us both socially
and economically. I urge my Lords to consider these economic benefits. In the UK, cost of
age-related diseases is staggering, amounting to billions of pounds annually. Dementia
alone costs UK economy £34.7 billion a year, and the economic burden of age-related
diseases is projected to ride rapidly as our population continues to age.
Just imagine, by developing therapies that reverse age-related diseases we can allow people
not only to live longer but more importantly in good health. The Office for National
Statistics estimates that increasing the state pension age could keep people working longer
and add £55 billion annually to the UK economy. Just a 20% reduction in six major diseases
would lead to an annual GDP boost of almost £20 billion, according to Andrew Scott and
the Global Institute. Now obesity treatment has been revolutionised through breakthrough
drugs like Ugovi. These address the underlying causes rather than just symptoms. My Lords,
whilst Denmark, S Wagovi and Ozempic are shrinking waistlines of celebrities, it is
swelling Denmark's economy and its GDP is predicted to grow 2.1% just this year thanks to
these drugs.
We need the paradigm shift and approach ageing with the same mindset, tackling it as a
medical condition itself and not focusing solely on downstream illnesses. By becoming the
first country to trick treat this as a medical condition, we can chart cause for more effective
interventions and improved health outcomes. A future where ageing no longer means an
inevitable decline, but instead the continued opportunity for vitality and productivity well
into our 80s and beyond. The science is now moving as rapidly as the AI revolution and
will be similarly, if not more impactful. And so, my Lords, it deserves just as much
attention.

Если продление жизни смогут получить только самые богатые, то ничего хорошего. Но это очень маловероятно. Даже чисто из экономических соображений. Сотни стартапов разрабатывают терапии, вложены миллиарды долларов. Они хотят получить прибыль, как можно больше. А на одних миллиардерах можно заработать сильно меньше, чем если сделать терапии доступными для миллиардов людей.

Шульман конечно та еще проповедница выученной беспомощности но да, если старики перестанут умирать жить станет хуже.
А смерть супербогатых что изменит? Они ведь умирая не дропают лут